Professional Documents
Culture Documents
com
Division of Pediatric
Neurology, Department of
Pediatrics, University of
Saskatchewan, Saskatoon,
Saskatchewan, Canada
2
Division of Medical Genetics,
Department of Pediatrics,
University of Saskatchewan,
Saskatoon, Saskatchewan,
Canada
3
Division of Neurosurgery,
Department of Surgery,
University of Saskatchewan,
Saskatoon, Saskatchewan,
Canada
4
Division of Pediatric
Orthopedics, Department of
Surgery, University of
Saskatchewan, Saskatoon,
Saskatchewan, Canada
5
Division of Developmental
Pediatrics, Department of
Pediatrics, University of
Saskatchewan, Saskatoon,
Saskatchewan, Canada
Correspondence to
Dr Richard J Huntsman,
Division of Pediatric Neurology,
Department of Pediatrics,
University of Saskatchewan,
103 Hospital Drive, Saskatoon,
Saskatchewan S7N-0W8,
Canada;
dr.huntsman@usask.ca
Received 28 August 2014
Revised 25 October 2014
Accepted 29 October 2014
To cite: Huntsman R,
Lemire E, Norton J, et al.
Arch Dis Child Published
Online First: [ please include
Day Month Year]
doi:10.1136/archdischild2014-307443
ABSTRACT
Spastic diplegia is the most common form of cerebral
palsy worldwide. Many disorders mimic spastic diplegia,
which can result in misdiagnosis for the child with
resultant negative treatment and family counselling
implications. In this paper, the authors provide a brief
review of spastic diplegia and the various disorders in
the differential diagnosis. We also provide a diagnostic
algorithm to assist physicians in making the correct
diagnosis.
INTRODUCTION
Spastic diplegia is a form of cerebral palsy (CP)
where spasticity predominates in the lower extremities with minimal upper extremity involvement.
It is strongly associated with prematurity.1 It is the
most common subtype comprising 34% of all children in a multinational European CP study.2 Spastic
paraplegia refers to lower limb spasticity due to a
spinal cord lesion.
Although the causative cerebral lesion is static,
children with spastic diplegia typically go through a
progression of abnormalities of tone, posture and
gait. Standing and walking are acquired late with
equinovarus posturing of the ankles due to spasticity of the calf muscles.3 As the child ages, progressive spasticity of the hip exors and hamstrings can
result in a crouch gait, which makes prolonged
walking difcult, thus giving the appearance of
neurological deterioration.4
The most common cerebral lesion encountered
with spastic diplegia is periventricular leukomalacia
(PVL) characterised by bilateral necrosis of the
frontal and parietal periventricular white matter.5
The topographical distribution of the corticospinal
tracts in the frontal periventricular regions results
in the diplegic pattern of motor impairment.6 The
imaging features of PVL include enlarged scalloped
lateral ventricles, periventricular gliosis, loss of
white matter and thinning of the corpus callosum.7
PVL is identied in approximately 75% of all children with spastic diplegia.2 6
Excluding slowly progressive neurological disorders from a diagnosis of CP can be challenging as
both frequently share similar patterns of motor
impairment.8 In a highly consanguineous South
Asian population in Northern England, the number
of children diagnosed with CP was almost three
times that expected, indicating that genetic or
inherited metabolic disorders accounted for a high
percentage of these diagnoses.9
The American Academy of Neurology recommends that routine metabolic and genetic testing
not be performed unless there are features atypical
of CP on history and physical examination. All children diagnosed with CP should have neuroimaging,
DYSTONIA
Dystonia is a hyperkinetic movement disorder with
continuous contraction of agonist and antagonist
muscle groups causing sustained posturing of the
trunk or limbs. Clinically, dystonia can usually be
differentiated from spasticity by the presence of
rigidity throughout the entire range of movement
of the affected limbs and the lack of a spastic catch.
Transient dystonic toe walking typically presents
in early infancy with asymmetrical toe walking as
soon as the child starts to ambulate. The degree of
Copyright Article author (or their employer) 2014. Produced by BMJ Publishing Group Ltd (& RCPCH) under licence.
Review
Downloaded from http://adc.bmj.com/ on March 4, 2015 - Published by group.bmj.com
Figure 1 Demonstrating proposed diagnostic algorithm of child with presumed diagnosis of spastic diplegic cerebral palsy. The algorithm is weighted towards the clinical assessment of the child as
opposed to MRI ndings or metabolic/genetic evaluation. BCAA, branch chain aminoaciduria; BITW, benign idiopathic toe walking; CSF, cerebrospinal uid; DRD, dopa-responsive dystonia; HSP, hereditary
spastic paraplegia; PLS, primary lateral sclerosis; PVL, periventricular leukomalacia; TCS, tethered cord syndrome; TDTW, transient dystonic toe walking; UCD, urea cycle defect; 5-MTFH,
5-methytetrahydrofolate deciency.
Review
dystonic posturing of the ankle often uctuates. On examination, there is rigidity with resistance to passive movement of
the ankle in all directions. Unlike spasticity, this rigidity does
not change with leg position or with velocity of the passive
movement. Dystonic toe walking eventually resolves after
several months.13
Dopa-responsive dystonia (DRD) is an uncommon primary dystonia with a median age of onset of 6 years. It is frequently misdiagnosed as spastic diplegia.14 It usually presents with asymmetric
lower limb rigidity that gradually generalises by early adulthood.
At the time of presentation, most children have bilateral limb rigidity and equinovarus foot posturing. Lower limb tendon reexes
are brisk with ankle clonus, but the plantar response is usually
normal. Occasionally a striatal toe can be seen. The most striking
feature of DRD is marked diurnal variation of symptoms with
worsening of symptoms as the day progresses and near complete
resolution after sleep. This diurnal variation attenuates with age
and is no longer seen by adulthood.15 Other features that suggest
DRD are tremor and parkinsonism with decreased velocity of
rapid repetitive hand movements.16
Most cases are due to a mutation in the gene (GCH1) that
encodes the enzyme guanosine-5-triphosphate cyclohydrolase I
(GTPCH1) on chromosome 14q22.2. Inherited in an autosomal-dominant fashion, the penetrance rate is 35%100%
with a female predilection.17 GTPCH1 is the enzyme responsible for the synthesis of tetrahydrobiopterin (BH4), an essential
cofactor for the enzyme tyrosine hydroxylase that converts tyrosine to levodopa.15 Rare cases of autosomal-recessive DRD due
to homozygous mutations in the genes that code for GTPCH1
and tyrosine hydroxylase are seen. In cases associated with
GCH1 mutations, cerebrospinal uid analysis shows decreased
levels of dopamine metabolites.16 Genetic analysis is able to
detect up to 90% of mutations in the GCH1 gene.17 Treatment
with low-dose levodopa/carbidopa (45 mg/kg/day of levodopa)
will result in a marked resolution of symptoms with minimal
side effects.15 A therapeutic challenge with levodopa/carbidopa
should be considered in any child whose diagnosis of spastic
diplegia is uncertain due to the dramatic improvement in symptoms seen in children with DRD after a short period of
treatment.14
Review
intervention of tethered cord syndrome may result in improved
outcomes especially with regards to pain and prevention of
further motor decline.29
LEUKODYSTROPHIES
The leukodystrophies are genetically determined disorders
affecting myelin development within the central nervous
system.30 The clinical presentation of the leukodystrophies typically follows a period of normal development with progressive
bilateral spasticity. Behavioural and cognitive decline also occur,
which differs from spastic diplegia where cognitive delay, if
present, tends to be mild and is static.31 MRI often reveals symmetrical dysmyelination with increased T2 signal intensity in the
periventricular cerebral white matter with sparing of the subcortical U-bres. The pattern of cerebral dysmyelination seen on
MRI can be helpful in determining the aetiology of the
leukodystrophy.32
Several leukodystrophies such as Krabbe Disease, Metachromatic
Leukodystrophy and Juvenile Onset Alexander Disease have
late-onset forms with predominant lower limb spasticity. The spasticity can be slowly progressive with cognitive function remaining
intact, resulting in the appearance of a static process.3336 Sjogren
Larsson syndrome, a leukodystrophy due to decient activity of the
fatty aldehyde dehydrogenase component of fatty alcohol:NAD+
oxidoreductase, typically presents in the rst year of life with ichthyosis, developmental delay and lower limb spasticity. The presence of ichthyosis and moderate to severe developmental delay
differentiates this disorder from spastic diplegia. Cerebral MRI
reveals abnormal T2 changes throughout the frontal and parietal
white matter. Diagnosis can be conrmed with enzyme or genetic
analysis.30
developmental delay often with autism, epilepsy, ataxia and dyskinesia. The diagnosis is conrmed by measuring decreased
levels of 5-methyltetrahydrofolate in the cerebrospinal uid.
Treatment with folinic acid in early childhood may result in
improvement of symptoms.44
An inherited disorder affecting vitamin E metabolism and
transport results in a progressive spastic-ataxic gait associated
with loss of lower limb tendon reexes, upgoing plantar
responses and impaired proprioception. Dysarthria and gaze
palsies may also occur. Diagnosis is made by measuring serum
vitamin E levels, and response to vitamin E supplementation is
favourable.45
Tropical paraplegia causes lower limb spasticity without associated sensory decits. While most cases are due to chronic
human T-lymphotropic virus 1 infection, some cases such as
konzo and lathyrism seen in Africa and the Indian subcontinent
result from excessive consumption of foods containing neurotoxic substances.45
CONCLUSION
Recent advances in neuroimaging and molecular genetics have
improved the diagnosis of many neurological disorders that may
mimic spastic diplegia. Correctly identifying these conditions
rests rmly with the recognition that the patient has features on
history and physical examination atypical of spastic diplegia and
a strong index of suspicion that an alternate diagnosis may be
responsible.
The authors reemphasise the importance of obtaining the
expertise of a paediatric neurologist and medical geneticist with
expertise in metabolic disease as part of the multidisciplinary
team involved in the diagnosis and care of these children.46
While the disorders discussed in the preceding section and diagnostic algorithm are not an exhaustive differential diagnosis of
spastic diplegia, it is hoped that an awareness of these diagnostic
possibilities will help the clinician to recognise the possibility of
an underlying condition that has treatment or genetic implications for the patient and their families.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1
2
3
4
5
6
7
8
10
11
Review
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Lew SM, Kothbauer KF. Tethered cord syndrome: an updated review. Pediatr
Neurosurg 2007;43:23648.
Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol
2001;24:1124.
Fedrizzi E, Inverno M, Bruzzone MG, et al. MRI features of cerebral lesions and cognitive
functions in preterm spastic diplegic children. Pediatr Neurol 1996;15:20712.
Lyon G, Fattal-Valevski A, Kolodny EH. Leukodystrophies. Top Magn Reson Imaging
2006;17:21939.
Duffner KD, Barczykowski A, Kay DM, et al. Later onset phenotypes of Krabbe
disease: results of the world-wide registry. Pediatr Neurol 2012;46:298306.
Kamate M, Hattiholi V. Predominant corticospinal tract involvement in early-onset
Krabbe disease. Pediatr Neurol 2011;44:1556.
Zafeiriou DI, Kontopoulos EE, Michelakakis HM, et al. Neurophysiology and MRI in
late-infantile metachromatic leukodystrophy. Pediatr Neurol 1999;21:
8436.
Johnson AB, Brenner M. Alexanders disease: clinical, pathologic, and genetic
features. J Child Neurol 2013;18:62532.
Garcia-Cazorla A, Wolf NI, Serrano M, et al. Inborn Errors of metabolism and motor
disturbances in children. J Inherit Metab Dis 2009;32:61829.
Ogier de Baulny H, Dionisi C, Wendel U. Branch chain organic acidurias/acidaemias.
In: Saudubray JM, van den Berghe G, Walter JH. eds. Inborn metabolic diseases:
diagnosis and treatment. 5th edn. Berlin: Springer, 2012:27796.
Chiong MA, Procopis P, Carpenter K, et al. Late-onset nonketotic hyperglycinemia
with leukodystrophy and an unusual clinical course. Pediatr Neurol 2007;37:2836.
Davidson RS, Carroll NC. Cerebral Palsy associated with maple syrup urine disease.
J Pediatric Orthop 1982;2:16570.
Poll-The BT, Wandeers RJA, Ruiter JPN, et al. Spastic Diplegia and periventricular
white matter abnormalities in 2-methyl-3-hydroxybutyryl-Coa dehydrogenase
deciency, a defect of isoleucine metabolism: differential diagnosis with
hypoxic-ischemic brain diseases. Mol Genet Metab 2004;81:2959.
Sedel F. Inborn errors of metabolism in adults: a diagnostic approach to
neurological and psychiatric presentations. In: Saudubray JM, van den Berghe G,
Walter JH. eds. Inborn metabolic diseases: diagnosis and treatment. 5th edn. Berlin:
Springer, 2012:5574.
Prasad AN, Breen JC, Ampola MG, et al. Arginemia: a treatable genetic cayuse of
progressive spastic diplegia simulating cerebral palsy: case reports and literature
review. J Child Neurol 1997;12:3019.
Hyland K, Shoffner J, Heales SJ. Cerebral folate deciency. J Inherit Metab Dis
2010;33:56370.
Kumar N. Metabolic and toxic myelopathies. Semin Neurol 2012;32:1236.
Gupta R, Appleton RE. Cerebral palsy: not always what it seems. Arch Dis Child
2001;85:35660.
These include:
References
This article cites 40 articles, 3 of which you can access for free at:
http://adc.bmj.com/content/early/2014/11/18/archdischild-2014-30744
3#BIBL
Email alerting
service
Receive free email alerts when new articles cite this article. Sign up in the
box at the top right corner of the online article.
Topic
Collections
Notes